262 related articles for article (PubMed ID: 33503061)
1. Increased risk of falls and fractures in patients with psychosis and Parkinson disease.
Forns J; Layton JB; Bartsch J; Turner ME; Dempsey C; Anthony M; Ritchey ME; Demos G
PLoS One; 2021; 16(1):e0246121. PubMed ID: 33503061
[TBL] [Abstract][Full Text] [Related]
2. Increases in institutionalization, healthcare resource utilization, and mortality risk associated with Parkinson disease psychosis: Retrospective cohort study.
Wetmore JB; Li S; Yan H; Irfan M; Rashid N; Peng Y; Gilbertson DT; Shim A
Parkinsonism Relat Disord; 2019 Nov; 68():95-101. PubMed ID: 31679990
[TBL] [Abstract][Full Text] [Related]
3. Comparing the Incidence of Falls/Fractures in Parkinson's Disease Patients in the US Population.
Kalilani L; Asgharnejad M; Palokangas T; Durgin T
PLoS One; 2016; 11(9):e0161689. PubMed ID: 27583564
[TBL] [Abstract][Full Text] [Related]
4. Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
Ballard C; Isaacson S; Mills R; Williams H; Corbett A; Coate B; Pahwa R; Rascol O; Burn DJ
J Am Med Dir Assoc; 2015 Oct; 16(10):898.e1-7. PubMed ID: 26239690
[TBL] [Abstract][Full Text] [Related]
5. A 12-year population-based study of psychosis in Parkinson disease.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Goetz CG; Stebbins GT; Aarsland D; Alves G
Arch Neurol; 2010 Aug; 67(8):996-1001. PubMed ID: 20697051
[TBL] [Abstract][Full Text] [Related]
6. Falls and Fractures in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study.
Layton JB; Forns J; Turner ME; Dempsey C; Bartsch JL; Anthony MS; Danysh HE; Ritchey ME; Demos G
Drugs Real World Outcomes; 2022 Mar; 9(1):9-22. PubMed ID: 34718963
[TBL] [Abstract][Full Text] [Related]
7. Incremental health care resource utilization and costs associated among patients with Parkinson's disease psychosis and incident dementia: An analysis of medicare beneficiaries.
Rajagopalan K; Rashid N; Gopal D; Doshi D
Int J Geriatr Psychiatry; 2023 Nov; 38(11):e6017. PubMed ID: 37936540
[TBL] [Abstract][Full Text] [Related]
8. Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies.
Huang YF; Cherng YG; Hsu SP; Yeh CC; Chou YC; Wu CH; Chen TL; Liao CC
Osteoporos Int; 2015 Jun; 26(6):1723-32. PubMed ID: 25672807
[TBL] [Abstract][Full Text] [Related]
9. Fractures in the prodromal period of Parkinson disease.
Camacho-Soto A; Gross A; Searles Nielsen S; Miller AN; Warden MN; Salter A; Racette BA
Neurology; 2020 Jun; 94(23):e2448-e2456. PubMed ID: 32345729
[TBL] [Abstract][Full Text] [Related]
10. Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study.
Layton JB; Forns J; McQuay LJ; Danysh HE; Dempsey C; Anthony MS; Turner ME
Drug Saf; 2023 Feb; 46(2):195-208. PubMed ID: 36517664
[TBL] [Abstract][Full Text] [Related]
11. Adverse events among nursing home residents with Alzheimer's disease and psychosis.
Oliveria SA; Liperoti R; L'italien G; Pugner K; Safferman A; Carson W; Lapane K
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):763-74. PubMed ID: 16823890
[TBL] [Abstract][Full Text] [Related]
12. Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis.
Rajagopalan K; Rashid N; Doshi D
J Comp Eff Res; 2024 Jan; 13(1):e230114. PubMed ID: 38099518
[No Abstract] [Full Text] [Related]
13. Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson's Disease (1991-2010).
Stang CD; Mullan AF; Camerucci E; Hajeb M; Turcano P; Martin P; Mielke MM; Josephs KA; Splett M; Abler V; Boeve BF; Bower JH; Savica R
J Parkinsons Dis; 2022; 12(4):1319-1327. PubMed ID: 35213389
[TBL] [Abstract][Full Text] [Related]
14. Health care resource utilization patterns among patients with Parkinson's disease psychosis: analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics.
Rajagopalan K; Rashid N; Kumar S; Doshi D
J Med Econ; 2023; 26(1):34-42. PubMed ID: 36444507
[TBL] [Abstract][Full Text] [Related]
15. Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus.
Lapane KL; Jesdale BM; Dubé CE; Pimentel CB; Rajpathak SN
Diabetes Res Clin Pract; 2015 Aug; 109(2):411-9. PubMed ID: 26008723
[TBL] [Abstract][Full Text] [Related]
16. Comorbid Parkinson's disease, falls and fractures in the 2010 National Emergency Department Sample.
Beydoun HA; Beydoun MA; Mishra NK; Rostant OS; Zonderman AB; Eid SM
Parkinsonism Relat Disord; 2017 Feb; 35():30-35. PubMed ID: 27887896
[TBL] [Abstract][Full Text] [Related]
17. Risk of Hospitalized Falls and Hip Fractures in 22,103 Older Adults Receiving Mental Health Care vs 161,603 Controls: A Large Cohort Study.
Stubbs B; Perara G; Koyanagi A; Veronese N; Vancampfort D; Firth J; Sheehan K; De Hert M; Stewart R; Mueller C
J Am Med Dir Assoc; 2020 Dec; 21(12):1893-1899. PubMed ID: 32321678
[TBL] [Abstract][Full Text] [Related]
18. Falls and comorbidity: the pathway to fractures.
Jørgensen TS; Hansen AH; Sahlberg M; Gislason GH; Torp-Pedersen C; Andersson C; Holm E
Scand J Public Health; 2014 May; 42(3):287-94. PubMed ID: 24434943
[TBL] [Abstract][Full Text] [Related]
19. Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study.
Sawada H; Oeda T; Yamamoto K; Umemura A; Tomita S; Hayashi R; Kohsaka M; Kawamura T
BMC Neurol; 2013 Oct; 13():145. PubMed ID: 24119306
[TBL] [Abstract][Full Text] [Related]
20. Increased Risk of Falls, Fall-related Injuries and Fractures in People with Type 1 and Type 2 Diabetes - A Nationwide Cohort Study.
Rasmussen NH; Dal J; den Bergh JV; de Vries F; Jensen MH; Vestergaard P
Curr Drug Saf; 2021; 16(1):52-61. PubMed ID: 32900349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
